These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4214608)

  • 1. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Gams RA; Carpenter JT
    Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.
    Gottlieb JA; Baker LH; Quagliana JM; Luce JK; Whitecar JP; Sinkovics JG; Rivkin SE; Brownlee R; Frei E
    Cancer; 1972 Dec; 30(6):1632-8. PubMed ID: 4663966
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
    Gerner RE; Moore GE
    Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Vogel CL; Primack A; Owor R; Kyalwazi SK
    Cancer Chemother Rep; 1973 Feb; 57(1):65-71. PubMed ID: 4704105
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
    Gerner RE; Moore GE; Didolkar MS
    Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
    Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
    Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
    Luce JK; Thurman WG; Isaacs BL; Talley RW
    Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
    Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
    Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
    [No Abstract]   [Full Text] [Related]  

  • 10. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
    Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
    Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
    Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
    Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK; Friedman MA
    Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
    Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
    Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
    Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
    [No Abstract]   [Full Text] [Related]  

  • 17. Dacarbazine for malignant melanoma.
    Med Lett Drugs Ther; 1974 Mar; 16(6):27-8. PubMed ID: 4817357
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
    Komp DM; Land VJ; Nitschke R; Cangir A; Dyment P
    Cancer Chemother Rep; 1975; 59(2 Pt 1):371-6. PubMed ID: 1097094
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.